RxSight, Inc. (RXST)

7.81 -0.12 (-1.51%) USD  |  NASDAQ  |  Mar 05, 16:00
7.99 +0.18 (+2.30%) Pre-Market: 09:02
More

RxSight Net Change in Capital Expenditures (% of Quarterly Assets)

Net Change in Capital Expenditures (% of Quarterly Assets) Chart

View Net Change in Capital Expenditures (% of Quarterly Assets) for RXST.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Change in Capital Expenditures (% of Quarterly Assets) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Change in Capital Expenditures (% of Quarterly Assets) Range, Past 5 Years

View Net Change in Capital Expenditures (% of Quarterly Assets) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Change in Capital Expenditures (% of Quarterly Assets) Benchmarks

View Net Change in Capital Expenditures (% of Quarterly Assets) Benchmarks
Start Trial
Alphatec Holdings, Inc. Upgrade
Abbott Laboratories Upgrade
Accuray, Inc. Upgrade
Boston Scientific Corp. Upgrade
Plus Therapeutics, Inc. Upgrade